This federal Project Grant award with ID R61HL172269, totaling $724,064.00, was provided by the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The award will fund the development and evaluation of a multi-level, integrated intervention called "HTN-Urban" to improve hypertension control among adults living in urban Vietnam. Key components of the intervention include a storytelling program, home blood pressure...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), provides $156,576.00 to Wake Forest University Health Sciences to tailor a telemedicine-based hypertension management intervention for Black patients. The project aims to overcome challenges in clinic-based hypertension care by leveraging telemedicine to improve self-management support and provide more reliable blood pressure data to...
This federal Project Grant award of $633,755.00 from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) aims to develop and implement an integrated community-based approach called "Community Vital Signs (CVS)" to increase rates of blood pressure screening and connections to care for hypertension in Nigeria. The award supports a two-phase project. In the R61 phase (Year 1), the grantee, Oregon Health & Science University, will engage...
This federal Project Grant award for $648,073 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will support a study titled "The ADHINCRA Study: Addressing Hypertension Care in Africa." The study aims to implement and evaluate multilevel interventions, including team-based care and telehealth with home blood pressure monitoring, to improve hypertension control in Ghana and Nigeria. The research will be...
The National Institute of Neurological Disorders and Stroke (NINDS), under the federal Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) grant program, awarded a $459,270 Project Grant to The Trustees of Columbia University in the City of New York to develop and test a scalable, telehealth-delivered behavioral intervention that promotes self-regulation for blood pressure medication adherence and physical activity among stroke patients. The 5-year...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,410,766 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to the University of Florida to conduct a mixed methods comparative effectiveness analysis evaluating the implementation and impact of telehealth and home blood pressure monitoring strategies on blood pressure control during the COVID-19 pandemic. The key objectives of the five-year project are to: 1) evaluate trends and disparities in the utilization of...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will fund research to investigate the role of the acid ceramidase-sphingosine-1-phosphate (AC-S1P) pathway in the regulation of sodium excretion and the pathogenesis of salt-sensitive hypertension. The $467,473 award to Virginia Commonwealth University (VCU) will support a 5-year research...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $116,748 to Washington University in St. Louis to conduct advanced implementation research and enhance the PI's mentorship capabilities in global cardiovascular patient-oriented research. The key research activities include: 1) Analyzing the impact of team-based care on hypertension control rates in Nigeria, 2) Defining patient retention patterns in hypertension...
This Project Grant award of $302,960 from the National Institute on Aging's Aging Research program (CFDA 93.866) will support research to identify individuals who would benefit most from intensive blood pressure control for preventing cognitive decline and dementia, as well as those most likely to experience serious adverse events. The 2-year project, conducted by Harvard T.H. Chan School of Public Health, will employ advanced statistical methods and pooled data from multiple large-scale...
This $678,566 Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to investigate the role of EPAC signaling in regulating renal sodium handling and its potential as a therapeutic target for hypertension. The grant is funding researchers at the University of Texas Health Science Center at Houston to pursue three specific aims: 1)...